FYR Bio $8M Trigger: Pipeline Alert

🚀 Battle Card: FYR Bio

• Chris Booth, CEO 📧 <cbooth@fyr.bio>

• The $8M injection fuels FYR Bio’s push into oncology and neuroscience, making the FYR Bio sales trigger a clear signal for scalable multiomic analytics procurement. → Source

• Scaling EV-Omics analysis for diverse clinical applications

• Accelerating translational biomarker discovery under tight trial timelines

• Primary: Integrated EV-Omics Data Platform → Faster biomarker discovery &amp; optimized trial design

• Expansion: AI-Enabled Multiomic Analytics Suite → Real-time treatment response monitoring

• HQ: Missoula, MT

• Employees: ≈ 60

• Rev: ≈ $5 M

• Website: [fyr.bio](https://fyr.bio/)

🤼 Competitive Intel

• Seer — Proteogenomics / Multiomics
• Unique edge: Deep proteomic workflow with high throughput
• Evaluated by R&amp;D and bioinformatics leads for data depth

• NanoString — Spatial transcriptomics
• Unique edge: Robust spatial gene expression profiling
• Evaluated by head of translational oncology for tissue insights

• Grail — Liquid biopsy / multi-cancer early detection
• Unique edge: Large-scale genomic fragment analysis
• Evaluated by clinical operations for screening capabilities

• Adaptive Biotechnologies — Immune profiling
• Unique edge: TCR/BCR sequencing insights
• Evaluated by immunology leads for immune response markers

• Illumina — Next-gen sequencing
• Unique edge: Broad platform with established lab integrations
• Evaluated by clinical lab directors for pipeline compatibility

✅ Do-Now Checklist

Next Step

🧠 Copy My Prompt for Personalized Cold Outreach

────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY   = ❑<your company>❑
OFFER_BRIEF   = ❑Integrated EV-Omics Data Platform for faster biomarker discovery & optimized trial design❑
PROOF_METRIC  = ❑≈ TBD❑
CTA_STYLE     = ❑quick_call❑
TONE          = ❑friendly❑

────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME        = Chris
COMPANY     = FYR Bio
DEPT        = ≈ TBD
SIZE        = ≈ 60
BOTTLENECK  = Scaling EV-Omics analysis for diverse clinical applications
EVENT       = Closes $8 Million Financing
DETAIL      = FYR Bio Closes $8 Million Financing
PAIN        = Accelerating translational biomarker discovery under tight trial timelines
SRC         = https://vcnewsdaily.com/fyr-bio/venture-capital-funding/qtrgyxwpnk
SIM_CO      = ≈ TBD
WIN_METRIC  = ≈ TBD
NEXT_SIZE   = ≈ TBD
EMP_EST     = ≈ 60
REV_EST     = ≈ $5M

────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.
Validate any ≈ guesses via SRC.

EMAIL  (keep breaks):
Subject: ≈ 60-person ≈ TBD

Chris—noticed your ≈ TBD team is ≈ 60.

That’s when Scaling EV-Omics analysis for diverse clinical applications slows growth.

We helped ≈ TBD fix this with Integrated EV-Omics Data Platform for faster biomarker discovery & optimized trial design.

Result: ≈ TBD.  
Quick call?

PS—next bottleneck hits ≈ TBD.

DM ≤45 words, TONE:
Saw your post about FYR Bio Closes $8 Million Financing — Accelerating translational biomarker discovery under tight trial timelines.  
Integrated EV-Omics Data Platform for faster biomarker discovery & optimized trial design. ≈ TBD.  
Quick chat?